Skip to main content

Repare Therapeutics Inc(RPTX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Repare Therapeutics Inc

7171 Frederick-Banting Building 2 Suite 270
St-Laurent A8 H4S 1Z9 CAN
P: 857-412-7018
http://www.reparerx.com

Sectors & Indices

Sector
Industry
Employees

Profile

Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.

Key Executives

NameTitle
Lloyd M. SegalCEO/Director/President
Steve ForteCFO/Chief Accounting Officer/Executive VP
Maria KoehlerChief Medical Officer/Executive VP
Michael ZindaChief Scientific Officer/Executive VP